Call Us: 1.800.873.5297


Pradaxa Orders Issued in MDL 2385

Judge David Herndon, of the Southern District of Illinois, has issued three case management orders relating to In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL number 2385. The Initial Conference Order and Procedural Matters (CMO #1), Confidentiality Order (CMO #2), and Order Governing the Format of Production (CMO #3), were entered less than 10 […]


Judge Herndon Denies BIPI’s Motions to Dismiss

Defendant Boehringer Ingelheim Pharmaceutials, Inc. (“BIPI”) filed Motions to Dismiss in every case filed against the company. BIPI argued that the Plaintiffs failed to allege a cause of action in the Complaints against the company. BIPI argued in their Motions that the Pradaxa label properly warned against severe gastrointestinal bleeding, hemorrhagic stroke, and death (as […]


Pradaxa MDL Transferred to Judge Herndon (Southern District of Illinois)

Due to the large number of Pradaxa cases and likely hundreds more which we anticipate will be filed, a process has been established for consolidating the cases filed in the federal court system before a single judge for purposes of pre-trial discovery. Attorneys from around the country, including Schlichter Bogard and Denton’s Roger Denton, presented […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.